Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should infliximab be used as an adjuvant to IVIG in the treatment of children with Kawasaki disease who are at high risk for resistance to conventional therapy?

× No keyword cloud information.

5 in total

1. Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.

Authors: Kothandam Sivakumar; Sreeja Pavithran
Journal: Pediatr Cardiol Date: 2012-03-18 Impact factor: 1.655

2. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.

Authors: Debbie-Ann Shirley; Ina Stephens
Journal: Pediatr Infect Dis J Date: 2010-10 Impact factor: 2.129

3. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.

Authors: Mary Beth Son; Kimberlee Gauvreau; Jane C Burns; Elena Corinaldesi; Adriana H Tremoulet; Virginia E Watson; Annette Baker; David R Fulton; Robert P Sundel; Jane W Newburger
Journal: J Pediatr Date: 2010-12-03 Impact factor: 4.406

4. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.

Authors: Masaaki Mori; Tomoyuki Imagawa; Ryoki Hara; Masako Kikuchi; Takuma Hara; Tomo Nozawa; Takako Miyamae; Shumpei Yokota
Journal: J Rheumatol Date: 2012-02-15 Impact factor: 4.666

5. The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide.

Authors: Toshiaki Oharaseki; Yuki Yokouchi; Hitomi Yamada; Hiroshi Mamada; Satoshi Muto; Kiyomi Sadamoto; Noriko Miura; Naohito Ohno; Tsutomu Saji; Shiro Naoe; Kei Takahashi
Journal: Mod Rheumatol Date: 2014-01 Impact factor: 3.023

5 in total

3 in total

Should infliximab be used as an adjuvant to IVIG in the treatment of children with Kawasaki disease who are at high risk for resistance to conventional therapy?

1. Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.

2. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.

3. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.

4. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.

5. The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide.

Review 1. Corticosteroids for the treatment of Kawasaki disease in children.

Review 2. Corticosteroids for the treatment of Kawasaki disease in children.

3. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.